ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Yale Cancer Center Trial Identifies New Treatment Option for Certain Patients with T-Cell Lymphoma
December 14, 2021Newswise — The final results from a national phase 2 study including researchers from Yale Cancer Center show the drug tipifarnib increased survival rates for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The findings are being.. -
ASH18: Bluebird’s anti-BCMA has a ‘clear lead’ in a crowded field
January 02, 2019This year’s ASH saw a plethora of presentations on BCMA-targeting drugs, but analysts at Jefferies say Bluebird Bio’s CAR-T therapy bb2121 “is still leading the pack.”.... -
European approval for Takeda's Alunbrig in ALK+ advanced non-small cell lung cancer
November 28, 2018Takeda’s Alunbrig (brigatinib) has been granted marketing approval by the European Commission as a monotherapy to treat anaplastic lymphoma kinase-positive (ALK+) advanced non-small...
Pharma Sources Insight January 2025
